--- title: "688426.SH (688426.SH) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/688426.SH/news.md" symbol: "688426.SH" name: "688426.SH" parent: "https://longbridge.com/en/quote/688426.SH.md" datetime: "2026-03-14T05:00:40.194Z" locales: - [en](https://longbridge.com/en/quote/688426.SH/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/688426.SH/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/688426.SH/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688426.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688426.SH/news.md) # 688426.SH (688426.SH) — Related News ### [Hongkang Financial Report / 2025 EPS 6.1 Yuan Profit 407 Million Yuan](https://longbridge.com/en/news/278062982.md) *2026-03-06T09:01:53.000Z* > Semiconductor testing giant Hongkang (3587) announced its 2025 financial report, expecting annual revenue of NT$ 5.545 b ### [Cowin Biotech: Nine respiratory pathogen nucleic acid detection kits (fluorescent PCR method) obtained medical device registration certificate](https://longbridge.com/en/news/277749013.md) *2026-03-04T08:45:02.000Z* > Cowin Biotech's wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has independently developed ni ### [Cowin Biotech: Net profit loss of 103 million yuan in 2025](https://longbridge.com/en/news/277163093.md) *2026-02-27T08:19:47.000Z* > Cowin Biotech released its performance report, achieving a total operating revenue of 193 million yuan for the fiscal ye ### [With a tight cash flow, some employees claim to have not been paid for 5 months. When will KangLe WeiShi, the "first vaccine stock on the Beijing Stock Exchange," welcome its spring?](https://longbridge.com/en/news/276744291.md) *2026-02-24T13:49:16.000Z* > KangLe WeiShi (920575.BJ) is facing a tight cash flow, with employees claiming they have not been paid for 5 months, lea ### [Intraday News - Hongkang (3587) plummets -4.37% to report 210.0 yuan, with a trading volume of 569 shares](https://longbridge.com/en/news/275247075.md) *2026-02-09T01:07:26.000Z* > Hongkang (3587-TW) stock price plummeted 4.37%, closing at NT$ 210.0, with a trading volume of 569 shares. Today's decli ### [Revenue Flash - COPTON (4739) January revenue reached NT$ 889 million, with a year-on-year growth rate of 109.06%](https://longbridge.com/en/news/275102412.md) *2026-02-06T09:15:30.000Z* > COPTON (4739-TW) announced that its revenue for January 2026 was NT$ 889 million, with a year-on-year growth rate of 109 ### [Cowin Biotech's performance in 2025 will reduce losses, and its Helicobacter pylori products are currently in the market cultivation period | Directly covering the shareholder meeting](https://longbridge.com/en/news/274306454.md) *2026-01-30T12:11:15.000Z* > Cowin Biotech stated at its first extraordinary shareholders' meeting in 2026 that its performance is still in a loss st ### [Cowin Biotech expects a net loss attributable to shareholders of RMB 91.441 million to RMB 112 million in 2025](https://longbridge.com/en/news/274123542.md) *2026-01-29T09:16:04.000Z* > Cowin Biotech expects its net loss attributable to the parent company in 2025 to be between 91.441 million yuan and 112 ### [Transitioning from "fragmented governance" to "systematic governance," the strict regulation of listed companies enters a new stage](https://longbridge.com/en/news/273619404.md) *2026-01-25T21:14:40.000Z* > At the beginning of 2026, multiple listed companies were penalized due to the strict regulatory policies of 2025. Over 9